Liver Cancer Trial, Recruiting (NCT05931068)

Liver Cancer Trial, Recruiting NCT05931068 Sponsor: Academisch Ziekenhuis Maastricht Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05931068 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who are scheduled to have open liver surgery (removing 3 or more segments of the liver) at the MUMC+ hospital
People who understand Dutch well enough to give consent and follow instructions during the study assessments

Who may not be able to join:

People who have a scarred or hardened liver (a condition called cirrhosis)
People who are unable or unwilling to complete specific fitness and metabolism tests (a cycling or walking breathing test, and a test that measures how the body uses energy)
People whose primary treatment is liver ablation (a procedure that destroys liver tissue using heat, cold, or other methods, rather than surgical removal)
People whose surgery was stopped partway through because the cancer was found to be too widespread to treat (sometimes called "open-close surgery")

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: S.W.M. Olde Damink, MD MSc PhD, Maastricht University

Phone: +31 43 388 1499

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05931068

Sponsor: Academisch Ziekenhuis Maastricht

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: +31 43 388 1499

More information: https://clinicaltrials.gov/study/NCT05931068

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who are scheduled to have open liver surgery (removing 3 or more segments of the liver) at the MUMC+ hospital
People who understand Dutch well enough to give consent and follow instructions during the study assessments

Who may not be able to join:

People who have a scarred or hardened liver (a condition called cirrhosis)
People who are unable or unwilling to complete specific fitness and metabolism tests (a cycling or walking breathing test, and a test that measures how the body uses energy)
People whose primary treatment is liver ablation (a procedure that destroys liver tissue using heat, cold, or other methods, rather than surgical removal)
People whose surgery was stopped partway through because the cancer was found to be too widespread to treat (sometimes called "open-close surgery")

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Academisch Ziekenhuis Maastricht

Registry

ClinicalTrials.gov

Start date

1 May 2023

Est. completion

11 April 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Change in energy expenditure using direct calorimetry; Change in energy expenditure using indirect calorimetry

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov